New drug cocktail shows promise for tough lung cancer

NCT ID NCT05299125

First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 33 times

Summary

This study tests a combination of three drugs (amivantamab, lazertinib, and pemetrexed) as a first treatment for people with advanced non-small cell lung cancer that has a specific genetic change called an EGFR mutation. The goal is to see if this combo can keep the cancer from growing for at least 18 months. About 54 people who have not had treatment for their advanced cancer will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC NON-SMALL CELL LUNG CANCERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • BP - A Beneficência Portuguesa de São Paulo

    São Paulo, 01323-030, Brazil

  • Centro de Pesquisa em Oncologia do Hospital São Lucas da PUCRS

    Porto Alegre, Rio Grande do Sul, 91751-443, Brazil

  • Centro de Tratamento de Tumores Botafogo (Oncoclínicas)

    Rio de Janeiro, 22250-905, Brazil

  • Hospital Erasto Gaertner

    Curitiba, Paraná, 81520-060, Brazil

  • Hospital Evangélico de Cachoeiro de Itapemirim

    Cachoeiro de Itapemirim, Espírito Santo, 29308-065, Brazil

  • Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP

    Ribeirão Preto, São Paulo, 14015-010, Brazil

  • Hospital de Amor de Barretos

    Barretos, São Paulo, 14784400, Brazil

  • Hospital de Base de São José do Rio Preto

    São José do Rio Preto, São Paulo, 15090-000, Brazil

  • ICESP - Instituto do Câncer do Estado de São Paulo

    São Paulo, 01246-000, Brazil

  • INCA - Instituto Nacional de Câncer

    Rio de Janeiro, 20230-130, Brazil

  • Irmandade da Santa Casa de Misericórdia de Porto Alegre

    Porto Alegre, Rio Grande do Sul, 90050-170, Brazil

  • Liga Norte Riograndense Contra o Câncer

    Natal, Rio Grande do Norte, 59062-000, Brazil

  • Pronutrir - Oncologia e Nutrição

    Fortaleza, Ceará, 60810-180, Brazil

  • São Camilo Oncologia

    São Paulo, 04014-002, Brazil

Conditions

Explore the condition pages connected to this study.